Resources Contact Us Home
Browse by: INVENTOR PATENT HOLDER PATENT NUMBER DATE
 
 
Browse by Category: Main > Health & Medicine
Class Information
Number: 514/408
Name: Drug, bio-affecting and body treating compositions > Designated organic active ingredient containing (doai) > Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., o,s,se or te) or nitrogen as the only ring hetero atoms doai > Five-membered hetero ring containing at least one nitrogen ring atom (e.g., 1,2,3-triazoles, etc.) > The five-membered hetero ring consists of one nitrogen and four carbons
Description: Subject matter wherein the five-membered hetero ring consists of one nitrogen and four carbon atoms, e.g., pyrrolidine, etc.


Sub-classes under this class:

Class Number Class Name Patents
514/422 Additional hetero ring 1,660
514/423 C=x bonded directly to the five-membered hetero ring by nonionic bonding (x is chalcogen) 1,285
514/429 Carbocyclic ring bonded directly to the five-membered hetero ring 220
514/424 Chalcogen bonded directly to the five-membered hetero ring by nonionic bonding 630
514/428 Chalcogen bonded indirectly to the five-membered hetero ring by acyclic nonionic bonding 816
514/426 Nitrogen bonded directly to the five-membered hetero ring by nonionic bonding 256
514/410 Polycyclo ring system having the five-membered hetero ring as one of the cyclos 563
514/409 Spiro ring system 281
514/427 Two double bonds between ring members of the five-membered hetero ring (e.g., pyrrole, etc.) 473


Patents under this class:
1 2 3 4 5 6 7 8 9 10 11 12

Patent Number Title Of Patent Date Issued
5521210 Ophthalmic use of muscarinic agonists having increased duration of activity May. 28, 1996
5519041 Anti-neoplastic, anti-viral and ribonucleotide reductase activity affecting pharmaceutical compositions and methods of treatment May. 21, 1996
5514695 Anti-neoplastic, anti-viral and ribonucleotide reductase activity affecting pharmaceutical compositions and methods of treatment May. 7, 1996
5500436 2-(N-(2-aminomethyl)amino)acetic acid derivatives to inhibit advanced glycosylation Mar. 19, 1996
5498625 Substantially pure enantieners of 2-azabicyclo(2.2.1)hept-5-en-3-one Mar. 12, 1996
5498622 Anti-neoplastic, anti-viral and ribonucleotide reductase activity affecting pharmaceutical compositions and methods of treatment Mar. 12, 1996
5496837 Anti-neoplastic anti-viral and ribonucleotide reductase activity affecting pharmaceutical compositions and methods of treatment Mar. 5, 1996
5496839 Anti-neoplastic, anti-viral and ribonucleotide reductase activity affecting pharmaceutical compositions and methods of treatment Mar. 5, 1996
5496838 Anti-neoplastic, anti-viral and ribonucleotide reductase activity affecting pharmaceutical compositions and methods of treatment Mar. 5, 1996
5496841 Anti-neoplastic, anti-viral and ribonucleotide reductase activity affecting pharmaceutical compositions and method of treatment Mar. 5, 1996
5496840 Anti-neoplastic, anti-viral and ribonucleotide reductase activity affecting pharmaceutical compositions and methods of treatment Mar. 5, 1996
5489583 2-substituted 3-(4-amidinophenyl)propionic acid derivatives Feb. 6, 1996
5486527 Anticholinergic agents Jan. 23, 1996
5482958 Method for treating endometriosis Jan. 9, 1996
5475019 Method of treating anxiety-related disorders with 2-aminocycloaliphatic amide compounds Dec. 12, 1995
5472977 Method for the treatment of uterine fibroid desease Dec. 5, 1995
5466702 Anti-neoplastic, anti-viral and ribonucleotide reductase activity affecting pharmaceutical compositions and methods of treatment Nov. 14, 1995
5466702 Anti-neoplastic, anti-viral and ribonucleotide reductase activity affecting pharmaceutical compositions and methods of treatment Nov. 14, 1995
5453442 Methods for lowering serum cholesterol and inhibiting smooth muscle cell proliferation, restenosis, endometriosis, and uterine fibroid disease Sep. 26, 1995
5446053 Methods of inhibiting dysfunctional uterine bleeding Aug. 29, 1995
5441965 Methods of inhibiting thrombin Aug. 15, 1995
5441973 N-acyl-4-phenyl-pyrrolidin-2-ones and method for preparing Aug. 15, 1995
5430058 Pharmaceutical compositions comprising hydroxamate derivatives for iron removal Jul. 4, 1995
5426109 Phenylnaphthalene hydroxy acids Jun. 20, 1995
5422361 Stable cream and lotion bases for lipophilic drug compositions Jun. 6, 1995
5411933 Bromopropargyl quarternary ammonium compounds having antimicrobial activity May. 2, 1995
5407955 Methods for lowering serum cholesterol and inhibiting smooth muscle cell proliferation, restenosis, endometriosis, and uterine fibroid disease Apr. 18, 1995
5403858 New compositions containing taxane derivatives Apr. 4, 1995
5401768 2,5,6,7-tetranor-4,8-inter-m-phenylene PGI.sub.2, derivative, manufacturing process thereof and its use Mar. 28, 1995
5391563 Anti-neoplastic, anti-viral and ribonucleotide reductase activity affecting pharmaceutical compositions and methods of treatment Feb. 21, 1995
5340831 Muscarinic receptor antagonists Aug. 23, 1994
5340823 Organosilane derivatives, pharmaceutical compositions containing them and process for preparing same Aug. 23, 1994
5292775 Anti-neoplastic, anti-viral and ribonucleotide reductase activity affecting pharmaceutical compositions and methods of treatment Mar. 8, 1994
5280031 Cyclic azaaliphatic compounds with a nitroxy function, processes for the preparation thereof and pharmaceutical compositions containing them Jan. 18, 1994
5278185 Piperidine, Tetrahydropyridine and pyrrolidine compounds Jan. 11, 1994
5270339 Phenoxybenzene derivative Dec. 14, 1993
5250558 Substituted triazolinones, triazolinethiones, and triazolinimines as neurotensin antagonists used to treat psychosis Oct. 5, 1993
5250194 N-dodecyl heterocyclic compounds useful as industrial microbicides and preservatives Oct. 5, 1993
5250562 Stilbene derivatives Oct. 5, 1993
5248690 Method for treatment of neurodegenerative diseases Sep. 28, 1993
5236922 Method for treating depression using 1-(aminophenyl)-2-aminopropanone derivatives Aug. 17, 1993
5227395 Anti-platelet aggregating agent Jul. 13, 1993
5223498 Phenylamidine and phenylguanidine derivatives and their use as antidiabetic agents Jun. 29, 1993
5217970 Use of isoxazolin-3-one derivatives as antidepressants Jun. 8, 1993
5204350 Method of inhibiting osteoclast-mediated bone resorption by administration of N-heterocyclicalkyl-substituted phenyl derivatives Apr. 20, 1993
5192800 Glutaramide diuretic agents Mar. 9, 1993
5187185 Pesticidal 1-arylpyrroles Feb. 16, 1993
5173505 Anti-neoplastic, anti-viral and ribonucleotide reductase activity affecting pharmaceutical compositions and methods of treatment Dec. 22, 1992
5153228 9-amino-2-phenylbicyclo[3.3.1]nonanes and 9-amino-2-phenylbicyclo[3.3.1]non-2-enes and drugs containing them Oct. 6, 1992
5137888 N,N- substituted amines and use thereof in hair growth promotion Aug. 11, 1992

1 2 3 4 5 6 7 8 9 10 11 12


 
 
  Recently Added Patents
Connector
Plants and seeds of corn variety CV622625
Animal sorting paddle having a paddle head with an angled tip
Production and distribution supply chain optimization software
Air conditioner
Protocol stack that offloads a TCP connection from a host computer to a network interface device
Injection molded battery package
  Randomly Featured Patents
Supported catalysts and their treatment for the preparation of ethylene oxide
Radiator grill of a motor vehicle
Method for forming buried plug contacts on semiconductor integrated circuits
Manual window regulator
Seal assembly having a plastic annular sealing member with an integral sealing lip
High pressure sealing system and method
Method of preventing flow pattern in wet-type color image forming apparatus and system adopting the same
Security method for a smart card
Routing method and mobile terminal
Warp knitted fabric and process for its production